Search Results

Containing any of the words

Only of the type

SFDA and Saudi Innovation Club Sign MoU to Advance Digital Transformation and Innovation News

Rosiglitazone (AVANDIA, AVANDAMET and AVANDARYL)Safety Information Update Awareness Article

Means of Gaining Information about Food and Health in an Intranet Portal Poll News

Is it possible to import products accompanied by certificate for standards other than standards issued by SASO? FAQ

Guidance for the Storage and Transport of Time- and Temperature–Sensitive Pharmaceutical Products Regulations

Circular about Promotion of food products using names and packages analogues to Infant Formula and Toddler Milk Circulars

Saudi Food and Drug Authority warns that an important safety information regarding specific models of the SV0.5 FOLFusor and SV 0.5 lnfusor Elastomeric Infusion Pumps, has been issued Warnings

A Phase 2 Study for the Treatment of Anemia with Alpha (α)-Thalassemia to Determine the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) in Adults and Evaluate the Safety and Pharmacokinetics in Adolescents Drug Clinical Trial

A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF 06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE CROHN’S DISEASE Drug Clinical Trial

"Study H9X-MC-GBGC is a Phase 3, randomized, double-blind, placebo-controlled trial withan open-label extension that investigates the effect of the addition of dulaglutide (0.75 and1.5 mg/week) or placebo weekly to metformin and/or basal insulin on change from baselinein hemoglobin A1c at 26 weeks in children and adolescents with type 2 diabetes mellitus" Drug Clinical Trial